Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Isabelle Declercq"'
Autor:
Luc Van Zandweghe, Daniella Galdermans, K Pat, Isabelle Fabry, Ingel K. Demedts, Isabelle Declercq, Rika Van Herreweghe, Michiel Thomeer, Kurt G. Tournoy, Patrick Alexander, Sofie De Craene, Valerie Van Damme, Heidi Marien, Luc Vanmaele, Nele De Brucker, Paul Germonpré, Piet Vercauter, Rob Schildermans, Sofie Derijcke, Rebecca De Pauw, Elke Govaerts, Karl Govaert
Publikováno v:
Lung Cancer. 115:49-55
In patients with refractory or recurrent non-small-cell lung cancer (NSCLC) after first line chemotherapy, phase III trials showed superiority of nivolumab, an IgG4 programmed death-1 immune-checkpoint-inhibitor antibody, over docetaxel. We evaluated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4288e730578a87efc7d4db5c79a4d656
https://doi.org/10.1016/j.lungcan.2017.11.008
https://doi.org/10.1016/j.lungcan.2017.11.008
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 3(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f128c4bf51d1b0882484b01222e57a6e
https://pubmed.ncbi.nlm.nih.gov/18520810
https://pubmed.ncbi.nlm.nih.gov/18520810
Publikováno v:
Journal of Thoracic Oncology. (6):662-663
66-year-old man was treated with platinum-based induction chemotherapy (three cycles) followed by thoracic radiotherapy for stage IIIB non-small cell lung cancer. Because of the extent of the disease, high-dose thoracic radiotherapy was not feasible,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::270103f18c5c9b46b08a57ea445fc02c